Telix Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Telix Pharmaceuticals stock ranges from a low of $22 to a high of $23. The average analyst price target of $22.33 forecasts a 99.73% increase in the stock price over the next year.

Price Target: $22.33 (+99.73%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$22.33	$22	$23
Change	+96.78%	+99.73%	+96.78%	+105.72%

* Price targets were last updated on Jul 3, 2025.

Analyst Ratings

The average analyst rating for Telix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	2
Buy	0	0	0	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $23	Strong Buy	Initiates	$23	+105.72%	Jul 3, 2025
David Nierengarten Wedbush	Wedbush	Buy Reiterates $22	Buy	Reiterates	$22	+96.78%	Jun 12, 2025
David Nierengarten Wedbush	Wedbush	Buy Initiates $22	Buy	Initiates	$22	+96.78%	Jun 5, 2025
Laura Sutcliffe UBS	UBS	Strong Buy Maintains $21 → $22	Strong Buy	Maintains	$21 → $22	+96.78%	Jan 27, 2025
Laura Sutcliffe UBS	UBS	Strong Buy Initiates $21	Strong Buy	Initiates	$21	+87.84%	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.